These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10233346)

  • 1. Increased serum level of stem cell factor in association with disease progression of hyperpigmented mycosis fungoides.
    Yamamoto T; Katayama I; Nishioka K
    Br J Dermatol; 1999 Apr; 140(4):765-6. PubMed ID: 10233346
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperpigmented mycosis fungoides: a case report.
    Erbil H; Sezer E; Koseoglu D; Filiz N; Kurumlu Z; Bülent Taştan H; Demiriz M
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):982-3. PubMed ID: 17659014
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycosis fungoides with blast cell transformation.
    Harrington CI; Slater DN
    Arch Dermatol; 1978 Apr; 114(4):611-2. PubMed ID: 274101
    [No Abstract]   [Full Text] [Related]  

  • 4. Anetodermic mycosis fungoides: a new clinicopathological variant of mycosis fungoides.
    Requena L; González-Guerra E; Angulo J; DeVore AE; Sangueza OP
    Br J Dermatol; 2008 Jan; 158(1):157-62. PubMed ID: 17999702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperpigmentation as a peculiar presentation of mycosis fungoides.
    Lu YY; Wu CH; Lu CC; Hong CH
    An Bras Dermatol; 2017; 92(5 Suppl 1):92-94. PubMed ID: 29267458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poikilodermatous mycosis fungoides.
    Mataix J; Bañuls J; Lucas A; Belinchón I; Betlloch I
    Int J Dermatol; 2007 Sep; 46(9):950-1. PubMed ID: 17822499
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of mast cell and stem cell factor in hyperpigmented mycosis fungoides.
    Yamamoto T; Katayama I; Nishioka K
    Blood; 1997 Aug; 90(3):1338-40. PubMed ID: 9242575
    [No Abstract]   [Full Text] [Related]  

  • 8. Folliculotropic mycosis fungoides with extreme pilosebaceous involvement and hematological abnormalities.
    Mizuno-Ikeda K; Hamada T; Suzuki D; Morizane S; Watanabe T; Imada M; Okada K; Iwatsuki K
    Eur J Dermatol; 2014; 24(1):135-6. PubMed ID: 24589554
    [No Abstract]   [Full Text] [Related]  

  • 9. [The determination of receptor proteins in patients with mycosis fungoides].
    Faradzhev ZG; Bukhova VP; Parfenova TM
    Vestn Dermatol Venerol; 1990; (4):14-6. PubMed ID: 2167571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene polymorphisms in patch-stage mycosis fungoides.
    Hodak E; Akerman L; David M; Tambur AR; Kfir B; Maron L; Sulkes J; Klein T
    Acta Derm Venereol; 2005; 85(2):109-12. PubMed ID: 15823901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The applied significance of a study of the biochemiluminescence of the blood serum in patients with mycosis fungoides].
    Kutasevich IaF
    Vestn Dermatol Venerol; 1990; (3):42-6. PubMed ID: 2368493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tissue polypeptide antigen correlating with clinical course in a patient with mycosis fungoides: a potential disease marker?
    Hu SC; Chen GS; Wu CS; Lan CC
    Br J Dermatol; 2007 Aug; 157(2):423-5. PubMed ID: 17596161
    [No Abstract]   [Full Text] [Related]  

  • 13. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interleukin-15 levels are not elevated in patients with stage I and II mycosis fungoides.
    Sugaya M; Nakamura K; Tamaki K
    Acta Derm Venereol; 2000; 80(6):455. PubMed ID: 11243648
    [No Abstract]   [Full Text] [Related]  

  • 15. Follicular mucinosis associated with mycosis fungoides.
    Clark-Loeser L; Latkowski JA
    Dermatol Online J; 2004 Nov; 10(3):22. PubMed ID: 15748592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poiklodermatous variant of mycosis fungoides.
    Bukhari IA
    J Drugs Dermatol; 2006 Feb; 5(2):190-2. PubMed ID: 16485891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
    Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
    Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system involvement in stage 1b mycosis fungoides.
    Lally A; Hollowood K; Whittaker S; Turner R
    Br J Dermatol; 2007 Oct; 157(4):815-6. PubMed ID: 17635509
    [No Abstract]   [Full Text] [Related]  

  • 20. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
    Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
    J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.